Skip to search formSkip to main contentSkip to account menu

ilepatril

Known as: (4S,7S,12BR)-7-((2S)-2-(Acetylsulfanyl)-3-Methylbutanamido)-6-Oxo-1,2,3,4,6,7,8,12b-Octahydropyrido(2,1-A)(2)Benzazepine-4-Carboxylic Acid 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

AVE 7688

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade
Abstract Objective: The aim of the present study was to compare the preventive impact of treatment with a vasopeptidase inhibitor… 
2012
2012
Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
Highly Cited
2012
Highly Cited
2012
Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment.
PURPOSE Cornea confocal microscopy is emerging as a clinical tool to evaluate the development and progression of diabetic… 
2012
2012
Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
We have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural… 
2012
2012
Assessing diabetic neuropathy using corneal confocal microscopy.
  • N. Efron
  • Investigative ophthalmology & visual science
  • 2012
  • Corpus ID: 11779516
N europathy is a frequent complication of diabetes and is a major cause of morbidity and mortality, potentially affecting distal… 
2011
2011
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.
Highly Cited
2011
Highly Cited
2011
Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.
2011
2011
Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice
Review
2008
Review
2008
Ilepatril (AVE-7688), a vasopeptidase inhibitor for the treatment of hypertension.
  • R. Tabrizchi
  • Current opinion in investigational drugs
  • 2008
  • Corpus ID: 11705565
sanofi-aventis (formerly Aventis Pharma AG) is developing ilepatril (AVE-7688), a dual angiotensin-converting enzyme and neutral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License